This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH at the 51st Union World Conference on Lung Health

October 20, 2020 by PATH

Zambia photo.jpg

Treatment coordinator Shabnam Shaikh visits TB patients across Mumbai, India to help them stay on track with treatment. Here, she is pictured with 60-year-old TB patient Mr. Razi Khan. Photo: PATH/Ruhani Kaur

Tuberculosis (TB) continues to be the leading cause of death from an infectious agent, more than 25 years after the World Health Organization declared it a global emergency. COVID-19 has rightly drawn the world’s attention, but the pandemic will likely increase the number of deaths from TB due to interruptions in services, particularly detection and treatment. 

Join PATH at this year’s virtual Union Conference as we discuss our work in TB control and our vision for reimagining TB care to be more patient-centered and resilient, even amidst a pandemic.

Symposia

Ending TB in vulnerable populations through operational research, capacity building, and evidence-informed decision making in Eastern Europe and Central Asia (Find-Treat-All)
Wednesday, October 21, 15:00-16:20 Central European Summer Time
Dr. Olga Pavlova, PATH Ukraine, Support TB Control Efforts in Ukraine Project
Session: SP-09, Breaking the one size fits all paradigm: introduction of optimized case finding of TB among key populations in Ukraine

Meet the Experts Sessions

The use of technology to deliver care and treatment: Communication, patient education, and treatment adherence
Wednesday, October 21, 18:15-19:15 Central European Summer Time
Join PATH Ukraine’s Country Director, Katya Gamazina, and Bruce Thomas of The Arcady Group for an interactive session discussing technology for care and treatment, including insights on how we can use technology, and also have remote support to patients during times of crisis and how can we learn from this for broader implication.

Oral Abstract Sessions

Isoniazid preventive therapy interruptions and TB among people living with HIV in Democratic Republic of the Congo
Wednesday, October 21,
11:00-12:20 Central European Summer Time
Isoniazid preventive therapy (IPT) is a critical prevention intervention for people living with HIV (PLHIV) in high TB burden settings, such as the Democratic Republic of the Congo. However, isoniazid shortages result in frequent IPT interruptions among PLHIV. We analyzed data from the United States Agency for International Development (USAID)-funded Integrated HIV/AIDS Project in Haut Katanga to understand potential impact of isoniazid interruptions.
Dr. Ibou Thior, PATH Washington DC, Integrated HIV/AIDS Project inHaut Katanga
Session: OA-01-TB preventive therapy in HIV

Doubling TB preventive treatment enrollment rates among people living with HIV in Ukraine
Wednesday, October 21,
11:00-12:20 Central European Summer Time
Under the USAID-funded Challenge TB project, PATH used a data-driven, evidence-grounded advocacy approach to shift the management of TB preventive treatment (TPT) services for PLHIV in Donetsk Oblast from TB doctors to HIV specialists; this shift led to a doubling of PLHIV initiated on TPT.
Dr. Olga Pavlova, PATH Ukraine, Support TB Control Efforts in Ukraine Project
Session: OA-04-A holistic approach: experiences from Europe

Antiretroviral treatment prescription by TB doctors in Odeska Oblast, Ukraine - successful model of integration of services for patients with TB/HIV co-infection
Wednesday, October 21,
11:00-12:20 Central European Summer Time
In Ukraine, only HIV specialists are permitted to prescribe antiretroviral treatment (ART), which leads to delayed initiation and low ART coverage among TB patients. The USAID-funded Challenge TB Project has enabled TB doctors to prescribe ART, which has resulted in a significant increase of ART coverage and reduction of ART initiation delays.
Dr. Olga Pavlova, PATH Ukraine, Support TB Control Efforts in Ukraine Project
Session: OA-04-A holistic approach: experiences from Europe

Results of pilot of integrated diagnosis of TB and hepatitis C virus among HIV-positive incarcerated individuals using GeneXpert in Dnipropetrovska Oblast of Ukraine
Wednesday, October 21,
11:00-12:20 Central European Summer Time
This session highlights how using GeneXpert® as an integrated patient-centered approach for TB and hepatitis C diagnosis and HIV viral load determination among detainees and prisoners in Ukraine greatly reduced turnaround times and improved efficiencies and increased access to services for prisoners and detainees.
Svitlana Leontyeva, PATH Ukraine, Serving Life Project
Session: OA-04-A holistic approach: experiences from Europe

Purification of lipoarabinomannan from urine of patients with TB
Wednesday, October 21,
12:30-13:50 Central European Summer Time
A multistep approach to extract urinary lipoarabinomannan (uLAM) from patients with TB, which can be scaled to use on large specimen volumes, was developed and assessed. The resulting uLAM will be used to support generation and screening of new uLAM antibodies that may increase the sensitivity of TB LAM assays.
Jason Cantera, PATH Seattle, Diagnostics
Session: OA-05-Innovative TB diagnostics

The potential of mHealth to enhance and improve TB awareness and case detection in Tanzania
Wednesday, October 21 15:00-16:20
Central European Summer Time
There is significant potential to leverage mobile health (mHealth) technologies to increase TB detection and facilitate linkage to care. This session highlights how the implementation of an mHealth app was used to increase TB screening and awareness to reach the general public across 31 regions in Tanzania.
Eunice Moturi, KNCV Tanzania (in partnership with PATH)
Session: OA-06-Different approaches to improve treatment and care

Bundling innovations for public private mix: Experience of artificial intelligence augmented X-ray screening and TrueNat for diagnosis
Friday, October 23 11:00-12:20 Central European Summer Time
To increase TB case detection in Nagpur slums, a public- private mix intervention was implemented with a novel Qure.ai software installed in private sector chest X-ray labs. Presumptive TB patients with abnormal chest X-ray results were confirmed microbiologically using TrueLab tests in a public sector hospital and linked for public sector treatment.
Dr. Shibu Vijayan, PATH India, TB REACH Wave 6
Session: OA-26-Using digital technology for TB elimination

Finding the missing cases one-by-two: Testing contacts of people with presumptive TB to close TB and HIV case-finding gaps in Democratic Republic of the Congo
Saturday, October 24 12:45-13:50, Central European Summer Time
Community outreach efforts to identify missing cases are critical to achieving TB and HIV epidemic control goals. The USAID-funded integrated HIV/AIDS project in Haut Katanga piloted the one-by-two approach, which was successful in earlier diagnosis of people with TB or HIV who may otherwise have been missed or diagnosed later through usual tracing efforts.
Charlie Mungamulongoy, PATH DRC, Integrated HIV/AIDS Project in Haut Katanga
Session: OA-37-TB and HIV potpourri

Poster Discussion Sessions

Informal provider study for suboptimal referrals for TB screening in Nagpur, India
Wednesday, October 21, 10:00-11:00 Central European Summer Time
Dr. Shibu Vijayan, PATH India
Session: EP03-Digital technology in the fight against TB

Implementing a referral system for drug-resistant tuberculosis patients to maximize treatment linkages to the public sector and minimize the treatment initiation time in Mumbai, India
Wednesday, October 21,
10:00-11:00 Central European Summer Time
Dnyaneshwar Waman, PATH India
Session: EP03-Digital technology in the fight against TB

We work hand-in-hand with patients, partners, and governments to end tuberculosis.
Learn more